ADCY1 and pulmonary arterial hypertension: Likewise, the adenylate cyclase inhibitor, 2′,5′-dideoxyadenosine failed to inhibit the effects of treprostinil on cell growth in PAH cells, whereas it did in normal HPASMCs [9,16], as did the IP receptor antagonist, RO1138452 [16].